Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping

Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping

Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant...

Full description

Bibliographic Details
Main Authors: M. Y. Neufeld, F. Mawassi, A. Levy, T. A. Treves, A. D. Korczyn
Format: Article
Language:English
Published: Hindawi Limited 1993-01-01
Series:Behavioural Neurology
Online Access:http://dx.doi.org/10.3233/BEN-1993-6105
id doaj-12a7f82dae04447c9e09e29d9bf735d6
record_format Article
spelling doaj-12a7f82dae04447c9e09e29d9bf735d62021-07-02T09:24:08ZengHindawi LimitedBehavioural Neurology0953-41801875-85841993-01-0161333510.3233/BEN-1993-6105Transdermal Physostigmine—Absence of Effect on Topographic Brain MappingM. Y. Neufeld0F. Mawassi1A. Levy2T. A. Treves3A. D. Korczyn4Department of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelDepartment of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelIsrael Institute for Biological Research, Ness Ziona, IsraelDepartment of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelDepartment of Neurology, Tel-Aviv Sourasky Medical Center and Sackler School of Medicine, IsraelNine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.http://dx.doi.org/10.3233/BEN-1993-6105
collection DOAJ
language English
format Article
sources DOAJ
author M. Y. Neufeld
F. Mawassi
A. Levy
T. A. Treves
A. D. Korczyn
spellingShingle M. Y. Neufeld
F. Mawassi
A. Levy
T. A. Treves
A. D. Korczyn
Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
Behavioural Neurology
author_facet M. Y. Neufeld
F. Mawassi
A. Levy
T. A. Treves
A. D. Korczyn
author_sort M. Y. Neufeld
title Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_short Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_full Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_fullStr Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_full_unstemmed Transdermal Physostigmine—Absence of Effect on Topographic Brain Mapping
title_sort transdermal physostigmine—absence of effect on topographic brain mapping
publisher Hindawi Limited
series Behavioural Neurology
issn 0953-4180
1875-8584
publishDate 1993-01-01
description Nine patients with primary degenerative dementia (PDD) participated in an open trial of transdermal physostigmine (TPh). In order to evaluate the neurophysiologic effects of TPh, EEG data were recorded and compared at baseline and following 2 months of continuous treatment. There was no significant effect of TPh on EEG spectra in patients with PDD.
url http://dx.doi.org/10.3233/BEN-1993-6105
work_keys_str_mv AT myneufeld transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT fmawassi transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT alevy transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT tatreves transdermalphysostigmineabsenceofeffectontopographicbrainmapping
AT adkorczyn transdermalphysostigmineabsenceofeffectontopographicbrainmapping
_version_ 1721333155556753408

Similar Items